F2G
About:
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Website: http://www.f2g.com
Top Investors: Innovate UK, European Investment Bank, Forbion Capital Partners, Sofinnova Partners, Morningside Venture Investments
Description:
F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.
$383M
Manchester, Manchester, United Kingdom
1998-01-01
contact(AT)f2g.com
David Denning
11-50
2024-09-12
Private
© 2025 bioDAO.ai